Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 9,150

Document Document Title
WO/2023/153294A1
The purpose of the present invention is to provide: a radiation-sensitive resin composition which enables the formation of a resist film having excellent sensitivity, LWR performance, water repellency and development defect reducing prop...  
WO/2023/149432A1
The objective of the present disclosure is to provide a composition with a stabilized fluorine-containing monomer, a method for stabilizing a fluorine-containing monomer, etc. The present disclosure relates to the following composition...  
WO/2023/143988A1
The present invention relates to a compound of formula (I) wherein X is selected from the group consisting of oxo, sulfanyl and hydroxy, and if X is hydroxy, the stereocenter in position (3) is in S configuration; R1 is selected from the...  
WO/2023/143455A1
The present application relates to a 3-[(benzo[d][1,3]dioxolane-4-yl)oxy]propylamine hydrochloride, a crystalline form thereof, and a preparation method therefor. A crystal form A of an (R)-N-methyl-3-phenyl-3-[(benzo[d][1,3]dioxolane-4-...  
WO/2023/144370A1
The current invention relates to an agrochemical composition comprising at least one agrochemical active component and a solvent. Furthermore, the present invention also relates to a method for applying aforementioned agrochemical compos...  
WO/2023/139163A1
Disclosed herein are novel 1,3-benzodioxole esters and their homologues, having various advantages over current compounds used in certain methods of drug-assisted therapy, such as MDMA, together with pharmaceutical compositions containin...  
WO/2023/138074A1
The present invention provides a method and system for preparing a cyclic carbonate by catalyzing carbon dioxide cycloaddition. The method comprises the following steps: carrying out a cycloaddition reaction by using a Schiff base metal ...  
WO/2023/137453A1
The present disclosure relates to compounds Formula (I): methods for making the compounds and methods for their use.  
WO/2023/134191A1
The present invention relates to the technical field of lithium battery electrolyte additives, and particularly discloses a method for purifying vinylene carbonate by coupled rectification-melt crystallization technology. The method comp...  
WO/2023/137446A1
The present disclosure relates to prodrugs of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA), methods for making the prodrugs and the methods for their use in treating brain and neurological disorders.  
WO/2023/129958A2
Provided herein are compounds of Formula (I), Formula (II), and Formula (III) or pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7 and A are defined herein. Also provided herein are pharmaceutical compositions ...  
WO/2023/127808A1
There is still a great amount of damage by pests or the like in production of agricultural crops, horticultural crops, and the like, and the development of novel pest control agents is desired due to factors such as the emergence of pest...  
WO/2023/127807A1
In the production of agricultural and horticultural crops, etc., damages caused by pest insects, etc. are still significant, and, therefore, the development of novel pest control agents has been required due to factors such as the emerge...  
WO/2023/120250A1
Provided is an actinic-ray-sensitive or radiation-sensitive resin composition, etc. that, when forming an ultra-fine pattern (for example, a line and space pattern of 25 nm or less, or a hole pattern with a hole diameter of 25 nm or less...  
WO/2023/117119A1
The present invention relates to the field of flavors and more specifically to new representatives of this group, in particular active ingredients having a sialagogue effect. The invention also relates to the use of these active ingredie...  
WO/2023/115002A1
The present disclosure relates to compound Formula (I) methods for making the compounds and methods for their use.  
WO/2023/114822A1
The disclosure relates to compounds of Formula (I), which are RXFP1 receptor agonists, compositions containing them, and methods of using them, for example, in the treatment of heart failure, fibrotic diseases, and related diseases such ...  
WO/2023/107877A1
Glycerol acetal sulfate and sulfonates, which may be used in consumer products to provide surfactant properties.  
WO/2023/103137A1
An orthoester mixture pharmaceutical excipient, relating to the field of pharmaceutical excipients, and mainly obtained by mixing different orthoester compounds in different proportions or by mixing orthoester compounds with biocompatibl...  
WO/2023/107715A1
The present invention discloses specialized combinations and methods of use thereof that may be used for beneficially modulating the central nervous system and for treating central nervous system, inflammatory, and metabolic disorders.  
WO/2023/098189A1
The present invention relates to the technical field of lithium battery additives. Disclosed are a preparation process for fluoroethylene carbonate and a lithium battery applying fluoroethylene carbonate. The preparation process comprise...  
WO/2023/098188A1
The present application relates to the technical field of lithium batteries, and specifically discloses a preparation method for vinylene carbonate, and a lithium battery electrolyte using vinylene carbonate. The purity of vinylene carbo...  
WO/2023/094830A1
Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof wherein Ring A, Ring B, R1, R2, R3 and L are as defined herein. The compounds are antagonists of the resistant (R-type) voltage-gated calcium ion ch...  
WO/2023/092195A1
Analogues of 3,4-methylenedioxymethamphetamine (MDMA), processes for their preparation, medicaments and medical methods of treatment comprising said MDMA analogues, and medical uses of said MDMA analogues. The MDMA analogues are capable ...  
WO/2023/092175A1
The invention relates generally to a compound of Formula (I), wherein R1 is a bicyclic fused heterocyclic moiety and R2 is H or F. The compound of Formula (I) or a pharmaceutically acceptable salt thereof has potential medical use in the...  
WO/2023/092044A2
Disclosed herein are salts and solid forms of MDMA, (R)-MDMA, (S)-MDMA, MDE, MDAI, MBDB, MEAI, and 5,6-Dimethoxy-2-aminoindane, including salts, solid forms of the compound and salts thereof, as well as polymorphs of solid forms. The sol...  
WO/2023/081895A1
Disclosed herein are isotopically enriched compounds and methods of using both isotopically and non-isotopically enriched compounds of the following formula (I), in the treatment of neurologic and brain disorders/conditions.  
WO/2023/078824A1
The present invention relates to compounds of the spiro-(indane- fluorene) type of formula (I), in particular those bearing a primary amino group and the corresponding diarylamino compounds. The invention further relates to methods for p...  
WO/2023/081403A1
Described herein are isotopically enriched analogs of methylone (e.g., deuterated analogs of methylone (e.g., (S)-methylone and (R)-methylone) with improved characteristics. Also described herein are salts (such as hydrochloride salt) an...  
WO/2023/078909A1
The present invention relates to compounds of formula (I), a delivery system based on photoresponsive cyclic acetal or ketal compounds capable of liberating in a controlled manner active volatile carbonyl compounds into the surrounding u...  
WO/2023/081899A1
Disclosed herein are isotopically enriched compounds and methods of using both isotopically and non-isotopically enriched compounds of the following formula (I) in the treatment of neurologic and brain disorders/conditions.  
WO/2023/081753A1
The present invention provides R-3,4-methylenedioxy-N,N-dimethylamphetamine, and salts thereof, for treating brain disorders.  
WO/2023/081897A1
Disclosed herein are isotopically enriched compounds of the formula (I), including enantiomers and mixtures thereof, as well as methods for their use and the use of MDE in treating neurologic and brain disorders.  
WO/2023/072285A1
Disclosed are an enoate compound containing an aromatic ring, and a preparation therefor and the use thereof. The compound of the present invention is simple in terms of structure and easy to synthesize. Synthetic raw materials are deriv...  
WO/2023/066026A1
The present invention relates to the technical field of chemical engineering, specifically to a method for purifying ethylene carbonate by means of dynamic crystallization. The method comprises the following steps: adding an ethylene car...  
WO/2023/069455A1
Disclosed herein are 3',4' "methylenedioxy" analogs of the natural alkaloids and analogs of mesembrine. For example, the present disclosure provides 3',4'-methylenedioxy-mesembrine, 3',4'-methylenedioxy-delta-7-mesembrenone, 3',4'-methyl...  
WO/2023/056102A1
The present disclosure provides prodrug compounds of MDMA, MDA, and derivatives thereof having an improved pharmacokinetic profile suitable for the treatment of various neurological diseases.  
WO/2023/051261A1
The present invention belongs to the field of insecticides and acaricides, and specifically relates to an imine compound and the use thereof. The structure is as represented by general formula I, wherein each substituent in the formula i...  
WO/2023/053977A1
The present invention provides a method for producing a salt (P) of an organic cation and an organic anion, the method comprising: (1) a step for obtaining a product which contains the salt (P) by subjecting a salt (I) of the organic cat...  
WO/2023/044027A1
Provided herein is a process for resolving the (S)- and (R)- enantiomers of a compound of Formula (I), wherein L, R1, and R2 are defined herein.  
WO/2023/036732A1
The present invention relates to the field of perfumery. More particularly, it concerns valuable new chemical intermediates for producing perfuming ingredients. Moreover, the present invention comprises also a process for producing compo...  
WO/2023/033073A1
The present disclosure pertains to: a production method that is for a compound represented by formula (1), and that comprises steps A, B, C, and D; and the like. (Step A) Reacting a compound represented by formula (2) with at least one b...  
WO/2023/029599A1
The present invention relates to a lipid compound. The lipid compound can be used alone, or can be used in combination with other lipid components such as neutral lipids, spotted lipids, steroids and/or analogs thereof, and/or polymer-co...  
WO/2023/032820A1
Provided are: a resin composition including at least one resin selected from the group consisting of cyclized resins and precursors thereof, and a compound B, which has a ring opening-polymerizable group, also has at least one structure ...  
WO/2023/029578A1
The present application relates to a lipid compound, which can be used separately, or used in combination with other lipid components such as a neutral lipid, a charged lipid, a steroid and/or an analog thereof, and/or a polymer-conjugat...  
WO/2023/031200A1
The present invention relates to malonamide compounds of the formula (I) where the variables are as defined in the claims and the description, and to compositions comprising these compounds. The invention also relates to the use of the s...  
WO/2023/027118A1
This resist composition generates an acid when being exposed to light and changes the solubility with respect to a developer through the action of the acid. The resist composition contains a compound including a cation (C0) represented b...  
WO/2023/028092A2
Provided are fluorinated analogs of MDMA, including fluorinated empathogens. In some embodiments, such compounds are monoamine releasers or inhibit monoamine transporters. In some aspects, features of the compounds provide stability, suc...  
WO/2023/019369A1
The present application includes a composition comprising a non-racemic mixture a compound of Formula (I) (R)-I, or a salt and/or solvate thereof, and (S)-I, or a salt and/or solvate thereof: wherein (R)-I, or a salt and/or solvate there...  
WO/2023/019298A1
The present invention relates to an improved method of synthesis of 1-(3',4'-methylenedioxyphenyl)-2-(methylamino)propane (MDMA) that is of sufficient purity that it can be used for pharmaceutical applications. In particular the present ...  

Matches 51 - 100 out of 9,150